We’re thrilled to announce that we are co-hosting the 2024 Science of Stability Conference, alongside FreeThink Technologies, Inc.
Taking place in Barcelona, Spain, the 8th SOS Conference promises to showcase the latest stability science discoveries and innovations, covering key topics on accelerated aging, degradation chemistry, and stability.
Discover more and register for the 2024 SOS on the event page.
Featured presentations
End points for forced degradation studies | Steve Baertschi, Ph.D., Baertschi Consulting and Dorina Kotoni, Ph.D., Novartis
Mass balance for forced degradation studies | John Campbell, Ph.D., GSK
Use of physicochemical calculators to augment the predicted likelihood of degradation products in Zeneth | Jonathan Lockett, Ph.D., Lhasa Limited
Risk-based predictive stability–an industry perspective | Alexander Abbott, AstraZeneca
Kinetics of moisture absorption in packaging | Anneleen Burggraeve, Ph.D., Janssen Pharmaceuticals
Oxygen sensitivity stability model | Patrick Kelleher, Ph.D., FreeThink Technologies
ASD crystallization predictions; their approach to predicting the shelf life of ASD | Christian Lübbert, Ph.D., amofor
Stability related dissolution slowdown | Luke Scrivens , AstraZeneca
Oligos and peptides (all synthetic) and applying ASAP routinely in new product development | Elisabeth Vey, Novartis
How do you go from investigation to GMP accelerated stability |Kenneth C. Waterman, Ph.D., FreeThink Technologies
Nitrosamine formation in pharmaceuticals: developing biased kinetic models to assess nitrosation risk in solid drug products | Ian W. Ashworth, Ph.D., AstraZeneca
Recent Developments in Modelling Drug Product Stability | Garry Scrivens, Ph.D., Pfizer